Transmyocardial laser revascularization with excimer laser: clinical results at 1 year Leonard Y Lee, MD, Maureen F O’Hara, RN, Eileen B Finnin, RN, Rory.

Slides:

Advertisements

Similar presentations

Uswa Shahzad, BHSc, Guangming Li, MD, Yaoguang Zhang, MD, Terrence M

Advertisements

Microwave Ablation for Atrial Fibrillation: Dose-Response Curves in the Cardioplegia- Arrested and Beating Heart Sydney L. Gaynor, MD, Gregory D. Byrd,

Manuel J. Antunes, MD, PhD, DSc

Intracostal sutures decrease the pain of thoracotomy

Management of Patients With Refractory Angina: Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines Michael McGillion, RN, PhD, Heather.

Induction of angiogenesis after TMR: a comparison of holmium:YAG, CO2, and excimer lasers G.Chad Hughes, MD, Alan P Kypson, MD, Brian H Annex, MD, Bangliang.

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,

Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database Traves D. Crabtree,

Louis A. Brunsting, MD, Robert S. Binford, MD, Kimberly C

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

50th Anniversary Landmark Commentary on Bove EL, Behrendt DM

Menno Huikeshoven, MS, Johan F Beek, MD, PhD, Jos A

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Michael Frenken, MD, Arno Krian, MD The Annals of Thoracic Surgery

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial Keith B Allen, MD, Robert D Dowling, MD, William W.

Long-Term Outcomes After Transmyocardial Revascularization

Right Gastroepiploic Artery Graft for Myocardial Revascularization: Prevalence of Atherosclerosis and Availability as a Conduit Kwang Ree Cho, MD, PhD,

Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R

Victor van Berkel, MD, PhD

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 1211 Leonard Y Lee, MD, Shailen.

Cardiac Resynchronization Therapy for the Failing Fontan Patient

Origins of the Cardiothoracic Surgery Network (CTSNet)

Ventricular assist device programs: design and function

G. Chad Hughes, MD, James E Lowe, MD, Alan P Kypson, MD, James D St

Instrumental validation of percutaneous transmyocardial revascularization: follow-up data at one year Alessandro S Bortone, MD, PhD, Donato D’Agostino,

Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy Giovanni Battista Luciani, MD, Giuseppe Montalbano,

Transmyocardial laser as an adjunct to minimally invasive CABG for complete myocardial revascularization Naresh Trehan, MD, Yugal Mishra, PhD, Yatin.

Seeing a tree through the forest: Precision medicine tools can enhance donor allocation in heart transplantation Vishnu Vasanthan, MD, Paul W.M. Fedak,

Support Your Specialty

On-pump versus off-pump coronary revascularization: evaluation of renal function Raimondo Ascione, MD, Clinton T Lloyd, Malcom J Underwood, Walter J Gomes,

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

Repair of aortic coarctation in patients more than 50 years of age

Outcome analysis of 245 CarboMedics and St

Editorial Board, January 2010

Neurocognitive Functioning in Patients Undergoing Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention: Evidence of Impairment Before.

Nitric oxide system in needle-induced transmyocardial revascularization Takayuki Saito, MD, PhD, Marc P Pelletier, MD, Hani Shennib, MD, Adel Giaid, PhD

Doppler tissue imaging to predict myocardial recovery during mechanical circulatory support Emmanuelle Vermes, MD, Rémi Houël, MD, Marc Simon, MD, Paul.

Luís Henrique W. Gowdak, MD, PhD, Isolmar T

Efficacy of transmyocardial laser revascularization and thoracic sympathectomy for the treatment of refractory angina Manuel Galiñanes, MD, PhD, Mahmoud.

Off-Pump Plication of Left Ventricular Aneurysm

Transmyocardial laser revascularization: experimental studies in healthy porcine myocardium Georg Lutter, MD, Juergen Martin, MD, Noriyuki Takahashi,

Repair of Thoracoabdominal Aortic Aneurysms in Octogenarians

Anthony P.C Yim, MD, Song Wan, MD, PhD, Tak Wai Lee, Ahmed A Arifi

Philip A. Linden, MD, Jon O. Wee, MD, Michael T

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Intracostal sutures decrease the pain of thoracotomy

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Neal S Goldstein, MD The Annals of Thoracic Surgery

Left ventricular functional improvement after transmyocardial laser revascularization Keith A Horvath, MD, Rodney Greene, BS, Noam Belkind, Bonnie Kane,

Absence of Cognitive Decline One Year After Coronary Bypass Surgery: Comparison to Nonsurgical and Healthy Controls Jerry J. Sweet, PhD, Eileen Finnin,

Transmyocardial revascularization using an XeCl excimer laser: Results of a randomized trial Jos A.P. van der Sloot, MD, PhD, Menno Huikeshoven, PhD,

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Niv Ad, MD, Sari D. Holmes, PhD, Deborah J

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

Denton A. Cooley, MD, O. H. Frazier, MD, Kamuran A

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Transmyocardial laser revascularization in the patient with unmanageable unstable angina Brack G Hattler, MD, PhD, Bartley P Griffith, MD, Marco A Zenati,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Prospective randomized trial of high thoracic epidural analgesia for coronary artery bypass surgery Colin Royse, MBBS, MD, Alistair Royse, MBBS, MD,

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

Adnan Cobanoglu, MD, Jess M Schultz, MD The Annals of Thoracic Surgery

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Aortic Valve Function After Bicuspidization of the Unicuspid Aortic Valve Diana Aicher, MD, Moritz Bewarder, Michael Kindermann, MD, Hashim Abdul-Khalique,

Safety of low hematocrits during cardiopulmonary bypass

Direct repair of giant right coronary aneurysm

Presentation transcript:

Transmyocardial laser revascularization with excimer laser: clinical results at 1 year Leonard Y Lee, MD, Maureen F O’Hara, RN, Eileen B Finnin, RN, Rory Hachamovitch, MD, Massamiliano Szulc, PhD, Paul D Kligfield, MD, Peter M Okin, MD, O.Wayne Isom, MD, Todd K Rosengart, MD The Annals of Thoracic Surgery Volume 70, Issue 2, Pages 498-503 (August 2000) DOI: 10.1016/S0003-4975(00)01484-3

Fig 1 Angina class before TMR and at 1 month, 3 months, 6 months, and 12 months following TMR. Canadian Cardiovascular Angina classification based upon direct questioning of patients at the timepoints indicated. The data are represented as mean ± standard deviation with the base line represented as the solid square and 1 month, 3 months, 6 months, and 12 months following TMR represented as open squares. ∗ p value comparing postoperational with base line timepoints (TMR = transmyocardial laser revascularization.) The Annals of Thoracic Surgery 2000 70, 498-503DOI: (10.1016/S0003-4975(00)01484-3)

Fig 2 Sublingual nitroglycerin intake per week before therapy and at 1 month, 3 months, 6 months, and 12 months following TMR. The data are represented as mean ± standard deviation with the base line represented as the solid square and 1 month, 3 months, 6 months, and 12 months following TMR represented as open squares. ∗ p value comparing postoperational with base line timepoints. (TMR = transmyocardial laser revascularization.) The Annals of Thoracic Surgery 2000 70, 498-503DOI: (10.1016/S0003-4975(00)01484-3)

Fig 3 Exercise tolerance testing–exercise duration before therapy and at 1 month, 3 months, 6 months, and 12 months following TMR. The data are represented as mean ± standard deviation with the base line represented as the solid square and I month, 3 months, 6 months, and 12 months following TMR represented as open squares. ∗ p value comparing postoperational with base line timepoints. (TMR = transmyocardial laser revascularization.) The Annals of Thoracic Surgery 2000 70, 498-503DOI: (10.1016/S0003-4975(00)01484-3)

Fig 4 Exercise tolerance testing ST/HR slope before therapy and at 1 month, 3 months, 6 months, and 12 months following TMR. ST/HR slope was determined from peak exercise regression of ST depression expressed as a positive value referenced to heart rate. The data are represented as means ± standard deviation with the base line represented as the solid square and 1 month, 3 months, 6 months, and 12 months following TMR represented as open squares. ∗ p value comparing postoperational with base line timepoints. (ST/HR = ST segment/heart rate slope; TMR = transmyocardial laser revascularization.) The Annals of Thoracic Surgery 2000 70, 498-503DOI: (10.1016/S0003-4975(00)01484-3)

Fig 5 Myocardial viability before therapy and at 3 months, 6 months, and 12 months following TMR. Myocardial viability was assessed by 24-hour redistribution thallium nuclear medicine scan at the timepoints indicated. The data are represented as means ± standard deviation with the base line represented as the solid square and 1 month, 3 months, 6 months, and 12 months following TMR represented as open squares. ∗ p value comparing postoperational with base line timepoints. (TMR = transmyocardial laser revascularization.) The Annals of Thoracic Surgery 2000 70, 498-503DOI: (10.1016/S0003-4975(00)01484-3)